TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999
TCL Archive Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities April 28, 1995
TCL Archive As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study November 21, 2014
TCL Archive DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer July 9, 1993
